Immediate Impact

75 hit
Sub-graph 1 of 21

Citing Papers

Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Hit
Age-Related Macular Degeneration
2024 Hit
4 intermediate papers

Works of Christopher Fecarotta being referenced

A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration
2010

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher Fecarotta 341 303 25 24 10 7 360
K. Vaitheeswaran 315 0.9× 256 0.8× 33 1.3× 62 2.6× 10 1.0× 11 381
Carlo Torrazza 326 1.0× 255 0.8× 23 0.9× 35 1.5× 25 2.5× 11 346
DS Friedman 289 0.8× 225 0.7× 28 1.1× 51 2.1× 8 0.8× 9 350
Franklin Luk 287 0.8× 202 0.7× 27 1.1× 17 0.7× 31 3.1× 8 396
Alan Margherio 301 0.9× 271 0.9× 19 0.8× 32 1.3× 5 0.5× 8 319
Hylton R. Mayer 264 0.8× 199 0.7× 13 0.5× 22 0.9× 25 2.5× 12 309
Koji Jian 341 1.0× 195 0.6× 9 0.4× 40 1.7× 12 1.2× 5 350
Sihong Mao 285 0.8× 222 0.7× 11 0.4× 41 1.7× 24 2.4× 10 311
David Faber 350 1.0× 227 0.7× 66 2.6× 26 1.1× 18 1.8× 11 389
Vesta C. K. Chan 285 0.8× 177 0.6× 51 2.0× 39 1.6× 5 0.5× 13 310

All Works

Loading papers...

Rankless by CCL
2026